Biomarker Card
This biomarker card gives comprehensive information about each biomarker.
Detailed Information | |
---|---|
Biomarker ID | 116 |
PMID | 17977648 |
Year | 2008 |
Biomarker | PP2A |
Biomarker Basis | Expression Based |
Biomolecule | mRNA |
Source | Tissue |
Subjects | Humans |
Regulation | Downregulated in PCa |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | Pathways Include:- TSGA14 |
Experiment | Benign Prostatic Hyperplasia (BPH) vs Prostate Cancer (PCa) |
Type of Biomarker | Diagnostic |
Cohort | 35 patients with Benign Prostatic Hyperplasia and 35 patients with Prostate cancer were compared. |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p=0.0073 |
Method Used | Immunohistochemistry |
Clinical | No |
Remarks | Only PP2A gene was validated on human patient cohort |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | PP2A |